A Fragment-based De Novo Design of VEGFR2/3 Inhibitors
碩士 === 國立臺灣大學 === 生醫電子與資訊學研究所 === 98 === Vascular endothelial growth factor receptor 2 and 3 (VEGFR-2/3) are important protein kinases targets for angiogenesis and lymphangiogenesis of cancer treatments. Most “Type I kinase inhibitors” are ATP competitive while “Type II kinase inhibitors” target the...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
2010
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/68288097730914016567 |